SCHEMBL8838149

SCHEMBL8838149

CCC(=O)C(CC(=O)ON1CCN(c2ccncc2)CC1)C1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 8/20 0.39
ITGA2B P08514 8/20 0.39
ADRB2 P07550 1/20 0.39
NCF1 P14598 1/20 0.39
PLD1 Q13393 1/20 0.39
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HRH3 Q9Y5N1 5/20 0.36
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
MMP2 P08253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8838104 0.83 SLC6A2 (0.40) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838018 0.83 SLC6A2 (0.40) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838053 0.82 ADRB2 (0.39) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838060 0.81 ADRB2 (0.39) ITGB3ITGA2BADRB2NCF1PLD1
SCHEMBL8837930 0.79 SPHK1 (0.39) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838037 0.77 SLC6A2 (0.41) ITGB3ITGA2BADRB2NCF1PLD1
SCHEMBL8837993 0.76 HRH3 (0.48) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838026 0.75 ADRB2 (0.38) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8837977 0.75 ADRB2 (0.38) ITGB3ITGA2BADRB2NCF1PLD1
Hydrochloric Acid SCHEMBL8838035 0.75 ADRB2 (0.38) ITGB3ITGA2BADRB2NCF1PLD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5700801-A ANTIINFLAMMATORY AGENTS, BONE DISORDERS KARL THOMAE, GMBH (DE) 1997-12-23 US disclosed